Alkaloids from African plants as pharmaceuticals to combat cancer drug resistance

Vaderament-A. Nchiozem-Ngnitedem,Justus Mukavi,Leonidah Kerubo Omosa,Victor Kuete
DOI: https://doi.org/10.1016/bs.abr.2024.02.010
2024-03-03
Advances in Botanical Research
Abstract:Cancer continues to be one of the major causes of mortality globally despite impressive advancements in the development of new therapeutic medications. Over the years, there has been an increasing concern regarding multidrug-resistant (MDR) cancer cell lines. Alkaloids are among the many plants' secondary metabolites that have been identified from African medicinal plants as potential cancer preventive agents. In this chapter, we summarized the phytochemistry and cytotoxic potential of alkaloids derived from plants native to Africa towards both drug-sensitive and drug-resistant cancer cells. A systematic search of the literature (using Google Scholar, PubMed, Scopus, and Science Direct databases) revealed 152 different alkaloids from African flora with anticancer and/or cytotoxic properties. This comprises naphthylisoquinoline (42.76%) , benzophenanthridine (9.87%), indolomonoterpenic alkaloids (9.87%), acridone (7.24%), furoquinoline (5.92%), bisbenzylisoquinoline (5.26%), steroidal (1.97%), β -carboline (1.32%) and other alkaloids (15.79%). Most studies on naphthyisoquinolines, which make up most anticancer alkaloids, have focused on drug-sensitive (CCRF-CEM) and multidrug-resistant (CEM/ADR5000) leukemia cell lines as well as Panc-1 human pancreatic cell lines. Based on the data presented here, alkaloids from African plants have shown highly promising anticancer potential. More in-depth studies should be undertaken to develop chemotherapeutic drugs to fight cancer including recalcitrant phenotypes.
plant sciences
What problem does this paper attempt to address?